Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated <i>Plasmodium falciparum</i> Malaria

Esther K Schmitt, Gilles Ndayisaba, Adoke Yeka, Kwaku Poku Asante, Martin P Grobusch, Etienne Karita, Henry Mugerwa, Stephen Asiimwe, Abraham Oduro, Bakary Fofana, Seydou Doumbia, Guoqin Su, Katalin Csermak Renner, Vinay Kumar Venishetty, Sarfaraz Sayyed, Judith Straimer, Ivan Demin, Sarita Barsainya, Caroline Boulton, Preetam Gandhi

Open source

DOI: 10.1093/cid/ciab716
Published: 2021-08-19
Container: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciab716,
  title = {Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated
                    <i>Plasmodium falciparum</i>
                    Malaria},
  author = {Esther K Schmitt and Gilles Ndayisaba and Adoke Yeka and Kwaku Poku Asante and Martin P Grobusch and Etienne Karita and Henry Mugerwa and Stephen Asiimwe and Abraham Oduro and Bakary Fofana and Seydou Doumbia and Guoqin Su and Katalin Csermak Renner and Vinay Kumar Venishetty and Sarfaraz Sayyed and Judith Straimer and Ivan Demin and Sarita Barsainya and Caroline Boulton and Preetam Gandhi},
  year = {2021},
  journal = {Clinical Infectious Diseases},
  doi = {10.1093/cid/ciab716},
  url = {https://doi.org/10.1093/cid/ciab716}
}

RIS

TY  - JOUR
TI  - Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated
                    <i>Plasmodium falciparum</i>
                    Malaria
AU  - Esther K Schmitt
AU  - Gilles Ndayisaba
AU  - Adoke Yeka
AU  - Kwaku Poku Asante
AU  - Martin P Grobusch
AU  - Etienne Karita
AU  - Henry Mugerwa
AU  - Stephen Asiimwe
AU  - Abraham Oduro
AU  - Bakary Fofana
AU  - Seydou Doumbia
AU  - Guoqin Su
AU  - Katalin Csermak Renner
AU  - Vinay Kumar Venishetty
AU  - Sarfaraz Sayyed
AU  - Judith Straimer
AU  - Ivan Demin
AU  - Sarita Barsainya
AU  - Caroline Boulton
AU  - Preetam Gandhi
PY  - 2021
JO  - Clinical Infectious Diseases
DO  - 10.1093/cid/ciab716
UR  - https://doi.org/10.1093/cid/ciab716
ER  -

APA

Schmitt, E. K., Ndayisaba, G., Yeka, A., Asante, K. P., Grobusch, M. P., Karita, E., Mugerwa, H., Asiimwe, S., Oduro, A., Fofana, B., Doumbia, S., Su, G., Renner, K. C., Venishetty, V. K., Sayyed, S., Straimer, J., Demin, I., Barsainya, S., Boulton, C., & Gandhi, P. (2021). Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated <i>Plasmodium falciparum</i> Malaria. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciab716

Source records

crossref · retrieved 2026-09-25T16:57:23.221Z